Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

This observational study is tracking real-world experiences of Parkinson's disease patients in the U.S. who have been prescribed a continuous under-the-skin (subcutaneous) pump of apomorphine called ONAPGO. It's not testing a new drug — it's gathering data on how well this treatment works in everyday life outside of a clinical trial setting. **You may be eligible if...** - Your doctor has prescribed you ONAPGO for Parkinson's disease - You have enrolled in the nurse navigator support program that comes with the medication - Your doctor agrees you are a suitable study participant - You are willing and able to sign a consent form **You may NOT be eligible if...** - You have not been prescribed ONAPGO - Your doctor does not think study participation is appropriate for you - You are taking certain anti-nausea medications (like ondansetron or granisetron) at the same time as ONAPGO - You are allergic to apomorphine or any ingredient in ONAPGO, including sulfites Talk to your doctor to see if this trial is right for you.